SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: bioRxiv, 2020.04.03.024257, 28 S.
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2020
- Creator
-
Bojkova, Denisa
McGreig, Jake E.
McLaughlin, Katie-May
Masterson, Stuart G.
Widera, Marek
Krähling, Verena
Ciesek, Sandra
Wass, Mark N.
Michaelis, Martin
Cinatl, Jindrich
- DOI
-
10.1101/2020.04.03.024257
- URN
-
urn:nbn:de:hebis:30:3-727259
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:52 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bojkova, Denisa
- McGreig, Jake E.
- McLaughlin, Katie-May
- Masterson, Stuart G.
- Widera, Marek
- Krähling, Verena
- Ciesek, Sandra
- Wass, Mark N.
- Michaelis, Martin
- Cinatl, Jindrich
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2020
Other Objects (12)
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
Aprotinin inhibits SARS-CoV-2 replication
Enisamium inhibits SARS-CoV-2 RNA synthesis
Lack of antiviral activity of darunavir against SARS-CoV-2
In vitro activity of itraconazole against SARS-CoV-2
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2-Arbeitsschutzstandard
Targeting the pentose phosphate pathway for SARS-CoV-2 therapy
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Human mesenchymal stromal cells are resistant to SARS-CoV-2 infection under steady-state, inflammatory conditions and in the presence of SARS-CoV-2-infected cells
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
Aprotinin inhibits SARS-CoV-2 replication
Enisamium inhibits SARS-CoV-2 RNA synthesis
Lack of antiviral activity of darunavir against SARS-CoV-2
In vitro activity of itraconazole against SARS-CoV-2
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2-Arbeitsschutzstandard
Targeting the pentose phosphate pathway for SARS-CoV-2 therapy
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Human mesenchymal stromal cells are resistant to SARS-CoV-2 infection under steady-state, inflammatory conditions and in the presence of SARS-CoV-2-infected cells
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
Aprotinin inhibits SARS-CoV-2 replication
Enisamium inhibits SARS-CoV-2 RNA synthesis
Lack of antiviral activity of darunavir against SARS-CoV-2
In vitro activity of itraconazole against SARS-CoV-2
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2-Arbeitsschutzstandard
Targeting the pentose phosphate pathway for SARS-CoV-2 therapy
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants